XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Apr. 30, 2026
Apr. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Loss for the period $ (3,198,410) $ (2,070,760)
Items not involving cash    
Impairment of assets held for sale 0 311,530
Interest expense 3,915 220,709
Share-based compensation 1,076,226 258,415
Accretion expense 8,018 222,460
Interest income note receivable amortization (25,077) 0
Legal expenses added to line of credit facility 95,182 0
Loss on settlement of note receivable 0 155,727
Impairment of deferred financing asset 67,610 0
Non-cash working capital item changes:    
Receivables 2,761 12,501
Prepaid expenses (18,767) 28,292
Accounts payable and accrued liabilities (145,341) (39,228)
Related party payables (147,801) 50,695
Net cash used in operating activities (2,281,684) (849,659)
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds from mineral property contracted for sale 0 1,614,349
Net cash provided by investing activities 0 1,614,349
CASH FLOWS FROM FINANCING ACTIVITIES    
Private placement, net of issuance cost 6,976,922 0
Proceeds from stock options exercise 663,614 0
Proceeds from warrants exercise 48,822 0
Proceeds from loan 0 500,000
Shares subscribed in advance   1,636,006
Line of credit repayment (228,098) 0
Loan repayment 0 (816,941)
Net cash provided by financing activities 7,461,260 1,319,065
Change in cash and cash equivalents for the period 5,179,576 2,083,755
Cash and cash equivalents, beginning of period 2,783,348 243,669
Cash and cash equivalents, end of period $ 7,962,924 $ 2,327,424